Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration

阿加曲班 医学 阿司匹林 内科学 冲程(发动机) 巴曲酶 纤维蛋白原 凝血酶 血小板 机械工程 工程类
作者
Shengyu Xu,Wenjun Zhang,Yan Zhang,Xu Zhang,Ting Wu
出处
期刊:Discovery Medicine [Discovery Medicine]
卷期号:35 (175): 185-185 被引量:2
标识
DOI:10.24976/discov.med.202335175.19
摘要

The therapeutic outcomes for acute ischemic stroke (AIS) with early neurological deterioration (END) are adverse. Argatroban is a novel direct thrombin inhibitor, which is safe in the treatment of AIS, but its efficacy is controversial. This study sought to assess the therapeutic effect of argatroban as an adjunct to aspirin in the treatment of AIS patients with END. Patients' prognosis for the presence of END was also evaluated.Overall, 166 AIS patients with END were included in the study from June 2018 to June 2021 in The Affiliated Zhangjiagang Hospital of Soochow University. Patients were divided in the control group (aspirin alone) and the study group (aspirin combined with argatroban). General data of the patients were collected. Clinical indexes such as the modified Edinburgh-Scandinavian stroke scale (MESSS), and the serum fibrinogen (FIB) and neuropeptide Y (NPY) levels before and after treatment were also collected. Correlations between prognosis and general data, and FIB and NPY levels in AIS patients with END were analyzed by multivariate logistic regression. The performance of FIB and NPY levels in predicting patients' prognosis was further analyzed using receiver operating characteristic (ROC) curves.There was no significant difference in the general data, such as sex, age, course of disease and basic diseases between the 2 groups. After treatment, the MESSS score (13.08 ± 3.24 vs. 16.48 ± 3.32, p < 0.001), serum FIB level (2.72 ± 0.81 vs. 3.52 ± 0.71, p < 0.001), and NPY level (121.28 ± 17.34 vs. 152.09 ± 18.25, p < 0.001) of the study group was significantly lower than that of the control group. A further analysis revealed that the serum FIB (OR, odds ratio = 2.296, 95% confidence interval, CI: 1.437-3.669, p = 0.001) and NPY (OR = 1.020, 95% CI: 1.002-1.039, p = 0.031) levels were independent risk factors of patients' prognosis for the presence of END.Aspirin combined with argatroban significantly improved neurological impairment of AIS patients with END, which is worthy of clinical application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
星辰大海应助大橙子采纳,获得10
4秒前
4秒前
七QI完成签到 ,获得积分10
5秒前
8秒前
褚香旋完成签到,获得积分10
8秒前
一只狗东西完成签到 ,获得积分10
10秒前
宇老师发布了新的文献求助10
11秒前
12秒前
qiqi发布了新的文献求助30
14秒前
大橙子发布了新的文献求助10
17秒前
wzhang完成签到,获得积分10
18秒前
ken131完成签到 ,获得积分10
21秒前
myl完成签到,获得积分10
22秒前
728完成签到,获得积分10
28秒前
xiaofeng5838完成签到,获得积分10
28秒前
ronnie完成签到,获得积分10
28秒前
31秒前
寒冷芷蕊完成签到,获得积分20
31秒前
31秒前
Jane完成签到,获得积分10
31秒前
一氧化二氢完成签到,获得积分10
37秒前
凡事发生必有利于我完成签到,获得积分10
38秒前
yihaiqin完成签到 ,获得积分10
42秒前
轩辕剑身完成签到,获得积分0
42秒前
coolkid完成签到 ,获得积分0
43秒前
你怎么那么美完成签到,获得积分10
43秒前
游艺完成签到 ,获得积分10
46秒前
冬月完成签到 ,获得积分10
46秒前
薛乎虚完成签到 ,获得积分10
47秒前
48秒前
大胖完成签到,获得积分10
48秒前
野火197完成签到,获得积分10
52秒前
53秒前
量子星尘发布了新的文献求助10
56秒前
April完成签到,获得积分10
56秒前
周舟完成签到 ,获得积分10
59秒前
V_I_G完成签到 ,获得积分10
1分钟前
nick完成签到,获得积分10
1分钟前
高高高完成签到 ,获得积分10
1分钟前
彪壮的亦瑶完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038157
求助须知:如何正确求助?哪些是违规求助? 3575869
关于积分的说明 11373842
捐赠科研通 3305650
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022